ESMO Congress 2024: Abstracts

The abstract submission is now closed.

View the abstracts in the online programme

Abstract submission deadlines

Outcome notifications

Outcome notifications are expected to be made available to first authors and submitters on 10 July.
Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by mid August 2024.

Information for presenters

Detailed instructions for the preparation of slide presentations and/or posters will be made available on the ESMO website by mid July 2024, in the section “Information for Presenters”.

Titles of accepted regular abstracts are expected to be made available online by the end of July and titles of accepted LBAs by the end of August.

Abstract submission categories

Late-breaking abstracts (LBA)

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.

The final late-breaking abstract deadline of 7 August 2024 is under no circumstances to be considered as an extension of the general submission deadline.

Trial in progress abstracts (TiP)

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to the ESMO Congress 2024.

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis.

Presentation of accepted abstracts

The ESMO Congress 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

• Presidential Symposium - Oral presentations of cutting-edge and significant clinical practice-changing studies, followed by expert discussion and perspectives.
• Proffered Paper – Oral presentations of original data of superior quality, followed by expert discussion and perspectives.
• Mini Oral – Short oral presentation of good quality, followed by expert discussion and perspectives.
• Poster – Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts will be published in the ESMO Congress 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

Publication schedule of accepted abstracts

Details regarding the publication of accepted abstracts are available here.

ESMO Merit Travel Grants

A limited number of ESMO Merit Travel Grants to ESMO 2024 have been made available (upon application), and awarded to the following abstract presenters:

• Laura Algeri, Milan, Italy
• Guillaume Beinse, Paris, France
• Adele Bonato, Pisa, Italy
• Jorja Braden, Camperdown, Australia
• Mehdi Brahmi, Lyon, France
• Sitthichai Chanmaniloet, Bangkok, Thailand
• Elizabeth Connolly, Sydney, Australia
• Antonio Di Meglio, Villejuif,  France
• Arielle Elkrief, Montreal, Canada
• Francesco Facchinetti, Villejuif, France
• Takao Fujisawa, Kashiwa, Japan
• Annalice Gandini, Paris, Italy
• Marco Germani, Pisa, Italy
• Gahyun Gim, Rochester, NY, USA
• Diego Gomez Puerto, Barcelona, Spain
• Anderley Gordon, London, UK
• Lynn Gottmann, Vienna, Austria
• Adam Grippin, Houston, TX, USA
• Emily Grist, London, UK
• Niels Guchelaar, Rotterdam, Netherlands
• Christopher Hackenbruch, Tübingen, Germany
• Niels Heersche, Rotterdam, Netherlands
• Lotte Hoeijmakers, Amsterdam, Netherlands
• Franziska Ippen, Heidelberg, Germany
• Qing Ji, Hangzhou, China
• Sam Khan, Toronto, UK
• Markus Kleinberger, Vienna, Austria
• Shohody Kryllus, Giza, Egypt
• Daan Lanser, Rotterdam, Netherlands
• Pietro Lapidari, Villejuif, France
• Shuo Li, Guangzhou, China
• Anlin Li, Guangzhou, China
• Silvana Lobo, Porto, Portugal
• Jerold Loh, Singapore
• Alexander Lozano, Toronto, Canada
• Minke Lucas, Amsterdam, Netherlands
• Arianna Marinello, Villejuif, France
• Daniel Michaeli, Heidelberg, Germany
• Julia Caroline Michaeli, Munich, Germany
• Natalie Ngoi, Singapore
• Pantelis Nicola, Hinxton, UK
• Gerneiva Parkinson, Providence, RI, USA
• Cedric Pobel, Villejuif, France
• Emanuela Risi, Prato, Italy
• Adrien Rousseau, Villejuif, France
• Barend Sikkema, Rotterdam, Netherlands
• Junmin Song, Bronx, NY, USA
• Jose Tapia, Cardiff, UK
• Paolo Tarantino, Boston, MA, USA
• Robert Watson, Oxford, UK
• Jiaija Yuan, Beijing, China

EONS Novice Research Dissemination Award (NRDA)

This award is an initiative of the EONS Research Working Group that was launched in 2013. The award is intended to give cancer nurses, who are relatively new to research, an opportunity to present their research at an international conference. Therefore, it is only open to cancer nurses who have not yet presented their research outside their own country.